Primary Research · 2017
Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study
Hidese S, Ogawa S, Ota M, et al. · Acta Neuropsychiatrica, 2017
Key finding
8-week open-label study in major depressive disorder (n=20) found 250mg/day L-theanine improved depression, anxiety, sleep, and cognitive function scores — supporting adjunctive use alongside standard treatment.
About the supplement
L-Theanine
Dose · mechanism · evidence grade · safety →
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/27396868/
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.